The latest release from Chris Miller contains some interesting testimonials about Affimers and although most of it goes straight over my head there does seem to be an indication that this technology is gathering momentum pretty quickly.
Yes, the placement has been allocated which is great news and long term the £22mil will accelerate the progress considerably, but that kind of dilution has never been particularly welcome. However, I shouldn't complain really as I am still shifting money about in ISAs etc so as to make the most of Avacta's inevitable rise. I am also into RENE in a big way, another very promising company.
I EXPECT THAT HENDERSON WILL SUBSCRIBE AS THEY ALREADY OWN 16.5% OF THE COMPANY. I WOULD NOT BE SURPRISED TO FIND WOODFORD BUYING. IT SUITS THEIR STATED OBJECTIVES OF INVESTING IN MEDICAL COMPANIES WITH GREAT PRODUCTS WHICH NEED EXTRA CASH TO MOVE THEM ON EXPONENTIALY.
Moderna Therapeutics were chosen by CNBC as number 1 in a list of companies that are revolutionising the business landscape of America.See...CNBC disruptors.For Moderna to have identified the potential of Avacta affirmers is very impressive. Be happy
Datafeed and UK data supplied by NBTrader and Digital Look.
While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.